Moolec Science MLECW
NASDAQ MLECW
$0.02 +0.00 (+2.56%)
As of: Aug 19, 2026 · 2:06 PM EDT

Moolec Science (MLECW) Shares Outstanding (2022 - 2026)

Moolec Science (MLECW) posted Shares Outstanding (Entity) of $72.6 billion for Q4 2025, up 168417.43% sequentially from $43.1 million in Q2 2025, and up 571975.29% YoY from N/an in Q4 2024.

Moolec Science (MLECW) Shares Outstanding (2022 - 2026) Analysis & Trends

Moolec Science has reported Shares Outstanding (Entity) for 4 years, with the latest figure at $72.6 billion in Q4 2025.

  • Quarterly Shares Outstanding (Entity) rose 571975.29% year-over-year to $72.6 billion in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $72.6 billion (up 571975.29% YoY) and the FY2025 annual result came in at $43.1 million, up 11.02% from the prior year.
  • Shares Outstanding (Entity) rose to $72.6 billion in Q4 2025 per MLECW's latest filing, from $43.1 million in the prior quarter.
  • Over five years, Shares Outstanding (Entity) peaked at $72.6 billion in Q4 2025 and troughed at $1.5 million in Q2 2022.
  • A 4-year average of $6.1 billion and a median of $22.9 million in 2022 frame the typical range for Shares Outstanding (Entity).
  • The sharpest annual moves came in 2023 and 2025: Shares Outstanding (Entity) sank 41.92% in 2023, then jumped 571975.29% in 2025.
  • Over 4 years, Shares Outstanding (Entity) stood at $20.7 million in 2022, then sank by 41.92% to $12.0 million in 2023, then increased by 5.5% to $12.7 million in 2024, then surged by 571975.29% to $72.6 billion in 2025.
  • According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $72.6 billion, $43.1 million, and $12.7 million for Q4 2025, Q2 2025, and Q4 2024 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 253.70 Mn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 102.80 Mn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 62.19 Mn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 398.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 111.58 Mn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 133.61 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 241.70 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 217.35 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - 445.06 Mn
10 Moolec Science 8,617.72 -1.19 Mn - 430,886.00

Historic Data

Download Data
DateValue
Mar 31, 2026 726.12 Mn
Dec 31, 2025 726.12 Mn
Jun 30, 2025 430,886.00
Dec 31, 2024 126,927.00
Sep 30, 2024 388,121.00
Jun 30, 2024 388,121.00
Mar 31, 2024 4.19 Mn
Dec 31, 2023 120,315.00
Sep 30, 2023 74,070.00
Jun 30, 2023 306,230.00
Mar 31, 2023 250,414.00
Dec 31, 2022 207,163.00
Sep 30, 2022 14,652.00
Jun 30, 2022 14,652.00
Mar 31, 2022 206,677.00